Layer, Chiang, et al. Genome Biology
Alnylam, Max Planck Settle Suit Over Tuschl IP
Alnylam said that as part of the agreement, it would allow Merck, the parent company of one-time rival Sirna Therapeutics, to sub-license a portion of the disputed IP to which it previously did not have access.
New to GenomeWeb? Register here quickly.